Mitera Biosciences

Funding and NIH signals

• SEC Form D raise Raised $1.1M (Form D filed May 6, 2026). SEC Form D 0002022224-26-000001 (May 6, 2026)
  Evidence (1 event)

  • May 6, 2026 · SEC Form D 0002022224-26-000001
    Name of Issuer: Mitera Biosciences Inc.; CIK: 2022224; Address: Bellevue, WA; Submission type: D; Filing date: 2026-05-06; Industry Group: Biotechnology; Date of First Sale: 2026-04-21; Types of Securities Offered: Option/warrant, Security to be acquired, Other (Simple Agreement for Future Equity); Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 1100000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals